Tēnā koutou katoa,
We are seeking your feedback on the New Zealand Cancer Action Plan 2019–2029 (PDF, 1.5 MB) (the Plan).
The Ministry of Health has engaged with a number of cancer-sector stakeholders in the development of the Plan.
The following questions about the...More
66 people are told they have cancer every day.
Most New Zealanders will be impacted by cancer in their lifetime – either directly, or through friends or family members affected by cancer.
Right now, we are finalising the New Zealand Cancer Action Plan 2019-2029.
We want to hear...More
To provide high quality maternity care in New Zealand we need to underpin maternity practice with information that supports the care of women, babies and their family/whānau, continuity of care, best practice, and analytics.
The HISO 10050.2:2019 Maternity Care Summary Standard is designed...More
The Ministry of Health is embarking on a refresh of content in the New Zealand Health Survey (NZHS), which has been in continuous operation in its current form since 2011. The purpose of this refresh is to update NZHS content so that it better meets users' needs, while shortening the survey's...More
The Ministry of Health is embarking on a refresh of content in the New Zealand Health Survey (NZHS), which has been in continuous operation in its current form since 2011. The purpose of this refresh is to update NZHS content so that it better meets users' needs, while shortening the survey's...More
The Radiation Safety Act 2016 came fully into force on 7 March 2017. The Act is administered by the Ministry of Health’s Office of Radiation Safety.
The Act sets out high-level safety and security obligations in sections 9–12. There are many different types of radiation use and the...More
Riluzole is a glutamate agonist used in the management of amyotrophic lateral sclerosis (ALS).
Riluzole is a prescription medicine approved under section 23 of the Medicines Act 1981. The following condition regarding prescriber access to this medicine applies. More
This Medsafe consultation proposes labelling requirements for substances/groups of substances in medicines and related products that may cause an undesirable reaction (eg, allergies) in some people.
Unlike foods, most medicines and related products are not required to list all the...More
The Government has committed to establishing a Medicinal Cannabis Scheme to improve access to quality medicinal cannabis products through:
enabling the commercial cultivation of medicinal cannabis and the manufacture of medicinal cannabis products in New Zealand
setting...More
The Ministry and the National Lung Cancer Working Group (the Working Group) have worked together to develop a set of proposed quality performance indicators (QPIs) for lung cancer.
The proposed indicators have been selected to measure performance and drive quality improvement in lung...More
We are seeking your clinical review of proposed quality performance indicators for prostate cancer.
The Ministry and the National Urological Cancer Working Group (the Working Group) have worked together to develop a set of proposed quality performance indicators (QPIs) for prostate cancer. ...More
The Health Workforce directorate in the Ministry of Health is working to develop a small number of defined priorities to guide improvement actions for the New Zealand health and disability workforce during the period 2019-2024. To support this work, please fill out this survey for ranking and...More
The draft New Zealand Obstetric Ultrasound Guidelines have been developed by a working group of sector clinical experts, with support from the Ministry of Health.
New Zealand Obstetric Ultrasound Guidelines: Consultation document (Word, 8.0 MB)
New Zealand Obstetric Ultrasound...More
Consultation
A Therapeutic Products Bill (the Bill) is being developed to replace the Medicines Act 1981 (and its associated regulations) and establish a new regulatory scheme for therapeutic products. This consultation document is intended to be read alongside an exposure draft of the...More
Purpose
The Ministry of Health and the Ministry for Primary Industries are asking the natural health products industry to complete this questionnaire so that we can better understand business profiles. This will help us minimise the costs and maximise the benefits as far as is practical when...More
You are invited to review and provide comment on the draft Bowel Screening Histology Data Standard.
The National Bowel Screening Programme is a free programme for men and women aged 60–74 years eligible for publically funded health care. The primary objective of bowel screening is to...More
The Radiation Safety Act 2016 came fully into force on 7 March 2017. The Act is administered by the Ministry of Health’s Office of Radiation Safety.
The Act sets out high-level safety and security obligations in sections 9–12. There are many different types of radiation use and the...More
This is a second round of consultation, following our consultation in 2017, on ACART’s proposed changes to the guidelines for family gamete donation, embryo donation, the use of donated eggs with donated sperm (donated eggs/donated sperm) and clinic-assisted surrogacy (collectively, the...More
Consultation on an exposure draft of the Therapeutic Products Bill and an associated consultation paper is underway. The Bill is intended to repeal and replace the Medicines Act 1981 and establish a new regulatory scheme for therapeutic products. More
This document sets out possible wording for a new code of practice to be issued under the Radiation Safety Act 2016 for the safe transport of radioactive material by road, rail, sea and air.
The Act sets out high-level safety and security obligations in sections 9–12. There are many...More
Consultation on an exposure draft of the Therapeutic Products Bill and an associated consultation paper is underway. The Bill is intended to repeal and replace the Medicines Act 1981 and establish a new regulatory scheme for therapeutic products. More
Consultation on an exposure draft of the Therapeutic Products Bill and an associated consultation paper is underway. The Bill is intended to repeal and replace the Medicines Act 1981 and establish a new regulatory scheme for therapeutic products. More
As part of its response to ongoing concerns with the use of surgical mesh, the Ministry of Health is wanting to provide an opportunity for people who have been harmed by surgical mesh and their families/whānau to tell their stories.
It is important that any such opportunity is inclusive and...More
The National Bowel Screening Programme (NBSP) is a significant investment in reducing disease and death from one of New Zealand’s biggest cancer killers. The NBSP is our first screening programme for both men and women and, when fully implemented, is expected to detect 500 to 700 cancers every...More
Medsafe is seeking comments on a proposed warning statement regarding a fire hazard on the labels of paraffin-based skin products.
This risk was identified by the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK. The MHRA have received reports in which an...More
This short survey will help the Ministry of Health to have a better understanding of growth and weight monitoring in New Zealand and how Practice Management Systems could assist health practitioners with this task. More
This document seeks your comment on the proposed future direction and content of the Ministry of Health’s Strategy to Prevent and Minimise Gambling Harm 2019/20 to 2021/22. Your feedback is vital to help us develop the final strategy.
Included are draft proposals for:
the strategic...More
The National Ethics Advisory Committee (NEAC) is an independent advisor to the Minister of Health. NEAC was established in 2001 by section 16 of the New Zealand Public Health and Disability Act 2000.
The National Ethics Advisory Committee’s statutory functions are to:
provide advice...More
Posthumous reproduction involves the use of a person’s sperm or eggs, after their death. In some cases, it also involves the retrieval of these gametes very shortly after death or at a time when death is imminent. While scientific advances have made this form of reproduction possible, there are...More
The Ministry of Health is considering undertaking a number of changes to the National Health Index (NHI) system. Changes made will be included in the associated Consumer Health Identity Standard .
We seek comment to assist in establishing a) if a particular proposal should proceed at a...More
This consultation is aimed at pharmaceutical companies, health care professional organisations, and individuals involved in conducting, or who are subjects of, clinical trials of medicines.
Medsafe sought comment on a major revision of the Guideline on the Regulation of Therapeutic Products...More